Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H9N2O2S.Na |
| Molecular Weight | 280.278 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].O=C1NC(C(=O)[N-]1)(C2=CC=CS2)C3=CC=CC=C3
InChI
InChIKey=JUVAYOYHITVSBL-UHFFFAOYSA-M
InChI=1S/C13H10N2O2S.Na/c16-11-13(15-12(17)14-11,10-7-4-8-18-10)9-5-2-1-3-6-9;/h1-8H,(H2,14,15,16,17);/q;+1/p-1
| Molecular Formula | Na |
| Molecular Weight | 22.9898 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C13H10N2O2S |
| Molecular Weight | 258.296 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
CNS Activity
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
120 mg 3 times / day steady, oral Recommended Dose: 120 mg, 3 times / day Route: oral Route: steady Dose: 120 mg, 3 times / day Sources: |
unhealthy, 16 years n = 1 Health Status: unhealthy Condition: epilepsy Age Group: 16 years Sex: M Population Size: 1 Sources: |
Disc. AE: Hepatic insufficiency... AEs leading to discontinuation/dose reduction: Hepatic insufficiency (1 patient) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Hepatic insufficiency | 1 patient Disc. AE |
120 mg 3 times / day steady, oral Recommended Dose: 120 mg, 3 times / day Route: oral Route: steady Dose: 120 mg, 3 times / day Sources: |
unhealthy, 16 years n = 1 Health Status: unhealthy Condition: epilepsy Age Group: 16 years Sex: M Population Size: 1 Sources: |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:40 GMT 2023
by
admin
on
Fri Dec 15 15:04:40 GMT 2023
|
| Record UNII |
0H34NO7B6N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0H34NO7B6N
Created by
admin on Fri Dec 15 15:04:40 GMT 2023 , Edited by admin on Fri Dec 15 15:04:40 GMT 2023
|
PRIMARY | |||
|
m888
Created by
admin on Fri Dec 15 15:04:40 GMT 2023 , Edited by admin on Fri Dec 15 15:04:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
510-34-9
Created by
admin on Fri Dec 15 15:04:40 GMT 2023 , Edited by admin on Fri Dec 15 15:04:40 GMT 2023
|
PRIMARY | |||
|
23662378
Created by
admin on Fri Dec 15 15:04:40 GMT 2023 , Edited by admin on Fri Dec 15 15:04:40 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |